Institution statistics

ASTRAZENECA - United Kingdom 

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:600-700
Total Number of Projects:100-200
Ranking timeline:

European project participation (2010-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 71
As coordinator: 0
As participant: 71
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 29.630.906 804.466 6
2019 0 155.605.429 2.382.538 15
2018 0 72.982.307 0 8
2017 0 66.648.068 0 7
2016 0 37.769.192 0 9
2015 0 10.088.161 0 3
2014 0 3.301.294 0 1
2013 0 32.185.152 1.876.531 9
2012 0 18.049.810 136.203 5
2011 0 29.398.001 0 5
2010 0 16.769.994 0 3
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
NOVARTIS PHARMA10
BAYER7
JANSSEN PHARMACEUTICA NV7
PFIZER LIMITED7
SANOFIAVENTIS7
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG5
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT5
KATHOLIEKE UNIVERSITEIT LEUVEN5
F HOFFMANNLA ROCHE4
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE4
KAROLINSKA INSTITUTE4
TAKEDA DEVELOPMENT CENTRE EUROPE4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD4
THE UNIVERSITY OF MANCHESTER4
UCB BIOPHARMA4
ELI LILLY AND COMPANY LIMITED3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM3
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
KING'S COLLEGE LONDON3
LEIDS UNIVERSITAIR MEDISCH CENTRUM3
MERCK SHARP & DOHME CORP3
STICHTING LYGATURE3
TEVA PHARMACEUTICAL INDUSTRIES LIMITED3
THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE3
UNIVERSITAET ZUERICH3
UNIVERSITY OF GLASGOW3
UNIVERSITY OF NEWCASTLE UPON TYNE3
UPPSALA UNIVERSITET3
ABBVIE INC2
ACADEMIC MEDICAL CENTRE AMSTERDAM2
ALLERGAN LIMITED2
CHARITE UNIVERSITAETSMEDIZIN BERLIN2
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL2
CLINIQUES UNIVERSITAIRES SAINTLUC2
DREEM2
DRESDEN UNIVERSITY OF TECHNOLOGY2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE2
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS2
FRIEDRICHALEXANDERUNIVERSITAET ERLANGEN NUERNBERG2
HELSE STAVANGER HF2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES2
INSTITUTO SUPERIOR TECNICO2
IXSCIENT LIMITED2
LEIDEN UNIVERSITY2
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV2
MCROBERTS BV2
MEDIZINISCHE UNIVERSITAET WIEN2
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN2
NORGES TEKNISKNATURVITENSKAPELIGE UNIVERSITET NTNU2
NOVO NORDISK2
PARKINSON'S DISEASE SOCIETY OF THEUNITED KINGDOM LBG2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON2
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU2
STICHTING MLC FOUNDATION2
STICHTING VUMC2
THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN HEREINAFTER TRINITY COLLEGE DUBLIN2
THE UNIVERSITY OF EXETER2
UNIVERSITA DEGLI STUDI DI GENOVA2
UNIVERSITA VITASALUTE SAN RAFFAELE2
UNIVERSITAET BASEL2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
UNIVERSITATSKLINIKUM ERLANGEN2
UNIVERSITE DU LUXEMBOURG2
UNIVERSITEIT TWENTE2
UNIVERSITEIT UTRECHT2
UNIVERSITY COLLEGE DUBLIN2
UNIVERSITY COLLEGE LONDON2
A PERSIDIS & SIA OE1
ABO AKADEMI1
ACADEMISCH ZIEKENHUIS GRONINGEN1
AGILENT TECHNOLOGIES FRANCE1
ALACRIS THERANOSTICS1
ALCEDIAG1
AMGEN LIMITED1
AMGEN RESEARCH1
ARTEEVO TECHNOLOGIES1
ASOCIACION PARKINSON MADRID1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASTELLAS PHARMA EUROPE BV1
ATRYS HEALTH1
AZIENDA OSPEDALE UNIVERSITA PADOVA1
AZIENDA OSPEDALIEROUNIVERSITARIA ANNA MEYER1
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION1
BELGIAN VASCULAR ANOMALY PATIENT ASSOCIATION1
BERRY CONSULTANTS LLP1
BIOCRATES LIFE SCIENCES1
BIOGEN IDEC LIMITED1
BRISTOLMYERS SQUIBB COMPANY CORP1
BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS1
BULL SAS1
BUNDESINSTITUT FUER RISIKOBEWERTUNG1
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE1
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL1
BYTEFLIES1
CAMBRIDGE COGNITION LIMITED1
CAMELOT BIOMEDICAL SYSTEMS1
CARNEGIE MELLON UNIVERSITY1
CELLECTRICON AB1
Constancy:

Total number of partners:464

Partner loyalty:
Frequent Partner: (> 2 projects): 120
Rare Partner: 344

Frequent / Rare Partner Ratio: 0.35

Diversity:

Subjects: Diversity index:0.43
Categories:
Category:No:
BIOLOGICAL SCIENCES1
SOCIAL AND ECONOMIC CONCERNS1

Project overview:

Start dateProjectacronymrolefundingpartners
2020-09-01NExt ApplicationS of Quantum Computing NEASQCparticipant4.671.33312
2020-09-01Prioritisation and Risk Evaluation of Medicines in the EnviRonment PREMIERparticipant4.550.00025
2020-07-01C-H Activation for Industrial Renewal CHAIRparticipant3.944.74413
2020-02-01Cooperation towards a sustainable chemical industry CO2PERATEparticipant4.156.28710
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69429
2020-01-01Multidisciplinary Training in Chronic Kidney Disease: from genetic modifiers to drug discovery TrainCKDisparticipant4.017.84811
2019-11-01Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases IDEA-FASTparticipant20.997.52346
2019-11-01EU Patient- cEntric clinicAl tRial pLatform EU-PEARLparticipant12.004.95336
2019-10-01PancREatic Cancer OrganoiDs rEsearch Network PRECODEparticipant3.992.89215
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99831
2019-09-01Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions 3TRparticipant40.273.19270
2019-06-01MachinE Learning Ledger Orchestration for Drug DiscoverY MELLODDYparticipant8.000.00017
2019-05-01Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug PD-MINDparticipant999.69810
2019-05-01INnate-ImmunomeTabolIsm as Antiviral TargEt INITIATEparticipant4.054.10614
2019-05-01Saracatinib Trial tO Prevent FOP STOPFOPparticipant999.7106
2019-04-01Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement MOBILISE-Dparticipant25.395.89734
2019-03-01A multidisciplinary approach towards sustainable improvement in rare diseases care uniting Europe's top class vascular research to find new treatment strategies for vascular anomalies V.A. Cureparticipant3.792.13617
2019-03-01Neurotoxicity De-Risking in Preclinical Drug Discovery NeuroDeRiskparticipant5.331.00018
2019-01-01FAIRplus FAIRplusparticipant3.996.15022
2019-01-01Stirling heat pump for high temperature industrial use Highliftparticipant2.439.5123
2019-01-01A European Training Network to Combat Bone Pain BonePainIIparticipant4.291.66512
2018-12-01Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe EUROoCparticipant3.942.86121
2018-12-01European Screening Centre; Unique Library for Attractive Biology ESCulabparticipant18.249.99320
2018-11-01European Health Data and Evidence Network EHDENparticipant14.105.75022
2018-06-01The GetReal Initiative GetReal Initiativeparticipant1.750.00017
2018-04-01DNA as a training platform for photodynamic processes in soft materials LightDyNAmicsparticipant3.827.59113
2018-03-01Nonlocal Methods for Arbitrary Data Sources NoMADSparticipant1.111.50025
2018-01-01Big Data for Medical Analytics BigMedilyticsparticipant14.997.30635
2018-01-01Big Data for Medical Analytics BigMedilyticsparticipant14.997.30635
2017-11-01Combatting Bacterial Resistance in Europe - Clostridium Difficile Infections COMBACTE-CDIparticipant2.312.30514
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88156
2017-09-01Improving Genome Editing Efficiency (IMGENE) IMGENEparticipant2.068.40910
2017-09-01Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFEparticipant20.000.00027
2017-01-01Molecular Tools for Nucleic Acid Manipulation for Biological Intervention MMBioparticipant3.971.34819
2017-01-01REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019 RESCEUparticipant14.498.12518
2017-01-01Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030 TransQSTparticipant8.000.00023
2016-11-01Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 PHAGOparticipant8.838.00020
2016-10-01Models Of Patient Engagement for Alzheimer’s Disease - Sofia ref.: 115985 MOPEADparticipant2.043.00015
2016-10-01Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 PREFERparticipant6.000.00033
2016-06-01PET Imaging in Drug Design and Development PET3Dparticipant3.901.24810
2016-02-01Targeted small-molecule Stabilisation of Protein-Protein Interactions TASPPIparticipant3.342.32312
2016-01-01ISOTOPIC LABELING FOR DRUG INNOVATION ISOTOPICSparticipant3.948.84413
2016-01-01Non-Noble Metal Catalysis - NoNoMeCat NoNoMeCatparticipant3.318.63415
2016-01-01Big Data in Chemistry BIGCHEMparticipant2.540.14617
2016-01-01Accelerated Early staGe drug diScovery AEGISparticipant3.836.99626
2015-11-01Synaptic Dysfunction in Alzheimer Disease SyDADparticipant3.846.73611
2015-09-01Exascale Compound Activity Prediction Engine ExCAPEparticipant3.910.1409
2015-01-01Advanced XFEL and Synchrotron based Probes of Protein Structure and Dynamics X-probeparticipant2.331.2859
2014-03-01"FLUOR21 : Synthesis, structure and function of fluorinated systems" FLUOR21participant3.301.2949
2013-11-01Academia and Industry Collaboration for Digital Pathology AIDPATHparticipant3.021.68911

overview shows latest 50 from 71 projects (2010-01-01 - 2020-12-31)
A full list of projects can be found here:

Alias institution names:
  • ASTRAZENECA
  • ASTRAZENECA AB
  • ASTRAZENECA INDIA PVT
  • ASTRAZENECA UK LIMITED

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum